Shorted
Avita Medical Inc. logo
AVH

Avita Medical

Pharmaceuticals, Biotechnology & Life Sciences

Avita Medical Inc. is a regenerative medicine company specializing in therapeutic skin restoration. Their flagship product, the RECELL System, is FDA-approved for treating thermal burn wounds and full-thickness skin defects. The company leverages patient-derived skin cells to enhance healing and accelerate recovery, positioning itself as a leader in acute wound care solutions.

Short position

short percentage0.12%
reported shorts88K
shares on issue73.297M

Avita Medical (ASX:AVH) has 0.12% of its shares on issue reported as short positions as of 5 Oct 2026, or about 88,026 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.14 percentage points. Its highest recorded short interest was 10.06% in November 2020. AVH is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Avita Medical (AVH) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
9 Aug

Can AVITA Medical (ASX:AVH) Turn RECELL Momentum Into More?

Highlights AVITA Medical has reported record quarterly revenue as stronger RECELL demand and contributions from newer wound-care products lifted commercial activity. Cash use improved considerably during the latest quarter, putting greater attention on whether the medical technology company can continue narrowing its funding gap. RECELL remains the centrepiece of AVITA Medicals strategy, but liquidity, debt obligations and the path towards sustainable cash generation remain important considerati...

Continue reading